Lucira Health Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Lucira Health Inc inventory turnover ratio, the Lucira Health Inc 's ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 3.36 in the third quarter 2022, a new company high. Average inventory processing period, for the Lucira Health Inc in Sep 30 2022 quarter, has decreased to 109 days, compare to 197 days, in the Jun 30 2022 quarter.

Within Healthcare sector 147 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2022, to 1151, from total ranking in the second quarter 2022 at 1769.

LHDX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lucira Health Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LHDX Inventory Turnover Ratio	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter
Y / Y Inventory Growth	29.47 %	230.48 %	317.34 %	943.7 %	-
Y / Y Cost of Sales Growth	802.78 %	45.17 %	841.84 %	2408.09 %	-
Inventory Turnover Ratio (TTM)	3.36	1.85	2.5	2.21	1.37
LHDX's Total Ranking	# 1151	# 1769	# 1577	# 1699	# 1767
Average inventory processing period	109	198	146	165	267
Seq. Inventory Growth	-53.48 %	64.02 %	43.58 %	18.18 %	18.74 %
Seq. Cost of Sales Growth	637.83 %	-64.09 %	3.85 %	228.11 %	18.65 %

Inventory Turnover Ratio Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 6
Healthcare Sector	# 148
Overall Market	# 1151

Inventory Turnover Ratio Statistics
High	Average	Low
3.36	2.16	0.89
(Sep 30 2022)		(Sep 30 2021)

LHDX Company Profile >> Back to LHDX Efficiency Comparisons >> Compare LHDX Inventory Turnover Ratio to its Competitors

Financial Statements
Lucira Health Inc 's Inventories	$ 56 Millions	Visit LHDX's Balance sheet
Lucira Health Inc 's Cost of Revenues TTM	$ 251 Millions	Visit LHDX's Income Statement
What are LHDX's Sales?		Visit LHDX's Sales by Segment

Other Inventory Turnover Ratios
Lucira Health Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
In Vitro & In Vivo Diagnostic Substances Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LHDX's Inventory Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LHDX's Competitors
Inventory Turnover Ratio for LHDX's Suppliers
Inventory Turnover Ratio for LHDX's Customers

You may also want to know
LHDX's Sales Growth Rates	LHDX's Pe Price to earnings ratio	LHDX's Receivables Turnover Ratio	LHDX's Stock Quote
LHDX's Net Income Growth Rates	LHDX's Ps Price to Sales ratio	LHDX's Sales per Employee	LHDX's Asset Turnover Ratio
LHDX's Net Margin	LHDX's Pb Price to Book ratio	LHDX's Financial Strength Ratios	LHDX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2022	Inventories at quarter ending Sep 30 2022
23andme Holding Co	12.00	$ 159.539 Millions	$ 13 Millions
Myriad Genetics Inc	11.77	$ 193.900 Millions	$ 16 Millions
Dmk Pharmaceuticals Corporation	11.69	$ 5.795 Millions	$ 0 Millions
Precipio inc	11.54	$ 6.899 Millions	$ 1 Millions
Universe Pharmaceuticals Inc	11.45	$ 18.252 Millions	$ 2 Millions
Rvl Pharmaceuticals Plc	11.30	$ 7.979 Millions	$ 1 Millions
Invitae Corporation	10.79	$ 420.518 Millions	$ 39 Millions
Clene Inc	10.50	$ 0.588 Millions	$ 0 Millions
Sunlink Health Systems Inc	10.48	$ 19.403 Millions	$ 2 Millions
Infusystem Holdings Inc	10.44	$ 45.803 Millions	$ 4 Millions
Sotera Health Company	10.05	$ 444.109 Millions	$ 44 Millions
Bgm Group Ltd	9.86	$ 58.628 Millions	$ 6 Millions
Cryo cell International Inc	9.83	$ 8.949 Millions	$ 1 Millions
Irhythm Holdings Inc	9.76	$ 125.900 Millions	$ 13 Millions
Semler Scientific inc	9.61	$ 5.236 Millions	$ 1 Millions
Eton Pharmaceuticals Inc	9.54	$ 4.944 Millions	$ 1 Millions
Lantheus Holdings Inc	9.53	$ 329.017 Millions	$ 35 Millions
Castle Biosciences Inc	9.39	$ 27.086 Millions	$ 3 Millions
Cardiff Lexington Corporation	9.32	$ 5.033 Millions	$ 1 Millions
Opko Health Inc	9.31	$ 792.963 Millions	$ 85 Millions
Qhslab Inc	8.91	$ 0.648 Millions	$ 0 Millions
Nutriband Inc	8.72	$ 1.320 Millions	$ 0 Millions
Agile Therapeutics Inc	8.66	$ 16.884 Millions	$ 2 Millions
Charles River Laboratories International inc	8.56	$ 2,008.284 Millions	$ 235 Millions
Camp4 Therapeutics Corporation	8.21	$ 163.980 Millions	$ 20 Millions
Star Equity Holdings Inc	7.99	$ 86.078 Millions	$ 11 Millions
Aveo Pharmaceuticals Inc	7.96	$ 11.496 Millions	$ 1 Millions
Lifemd Inc	7.76	$ 18.436 Millions	$ 2 Millions
Puma Biotechnology Inc	7.57	$ 50.153 Millions	$ 7 Millions
National Vision Holdings Inc	7.33	$ 921.089 Millions	$ 126 Millions

Date modified: 2026-08-29T17:43:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.